Numerous reagents have been developed to enable chemical proteomic analysis of small molecule-protein interactomes. However, the performance of these reagents has not been systematically evaluated and compared. Herein, we report our efforts to conduct a parallel assessment of two widely-used chemically-cleavable linkers equipped with dialkoxydiphenylsilane (DADPS linker) and azobenzene (AZO linker) moieties. Profiling a cellular cysteinome using iodoacetamide alkyne probe demonstrated a significant discrepancy between the experimental results obtained through the application of each of the reagents. To better understand the source of observed discrepancy, a mass tolerant database search strategy using MSFragger software was performed. This resulted in identifying a previously unreported artifactual modification on the residual mass of the azobenzene linker. Furthermore, we conducted a comparative analysis of enrichment modes using both cleavable linkers. This effort determined that enrichment of proteolytic digests yielded a far greater number of identified cysteine residues than the enrichment conducted prior to protein digest. Inspired by recent studies where multiplexed quantitative labeling strategies were applied to cleavable biotin linkers, we combined this further optimized protocol using the DADPS cleavable linker with tandem mass tag (TMT) labeling to profile the FDA-approved covalent EGFR kinase inhibitor dacomitinib against the cysteinome of an epidermoid cancer cell line. Our analysis resulted in the detection and quantification of over 10,000 unique cysteine residues, a nearly 3-fold increase over previous studies that used cleavable biotin linkers for enrichment. Critically, cysteine residues corresponding to proteins directly as well as indirectly modulated by dacomitinib treatment were identified. Overall, our study suggests that the dialkoxydiphenylsilane linker could be broadly applied wherever chemically cleavable linkers are required for chemical proteomic characterization of cellular proteomes.
Introduction
Chemical proteomics enables unbiased identification of small molecule-protein interactions in cellular systems 1 . One widely applied technique in chemical proteomics, termed activity-based protein profiling (ABPP), has been utilized in the identification of small molecule protein interactomes, characterization of entire protein families and probing the biology of proteins-of-interest 2 . More recently, the application of small molecule fragments to probe the reactivity of the cellular proteome has enabled new ways to target portions of the proteome long considered "undruggable" [3] [4] [5] [6] [7] . In most of the aforementioned studies, two critical questions must be addressed: the determination of the identities of the targeted proteins and the actual site of interaction between the small molecule and its protein target(s). Both questions have been successfully grappled with by utilizing a combination of small molecule probes forming irreversible conjugates with proteins and reagents that allow for selective capture and identification of protein targets by tandem mass spectrometry 2 .
Critically, a form of bioorthogonal transformation -copper catalyzed alkyne azide cycloaddition (CuAAC) -has been utilized to selectively couple small molecule probe-protein conjugates after cellular treatment with a tag that subsequently enables enrichment of engaged proteins and isolation of the probe-peptide adduct ( Figure 1A ). Those tags, typically referred to as cleavable biotin linkers, consist of three critical components: an azide group capable of reacting with an alkyne-derivatized fragment conjugated to a protein, a biotin group for enrichment, and finally, a cleavable moiety that allows for selective isolation of the adducted peptide ( Figure 1B) 8 . Pioneering work by Speers et al. utilized an enzymatically-cleaved biotin linker which enabled cellular profiling of reactive sites in a proteome 9, 10 . This approach was further extended to profiling the reactive cysteinome in mouse and human cell extracts 11 .
More recently, modifications to cleavable biotin linkers have enabled a diverse set of chemically-cleavable reagents which provide the advantage of decreased sample processing times due to faster cleavage conditions and small residual modifications on conjugated peptides, a highly desirable property that can affect the ability to determine the identities of these peptides 12, 13 . Different chemical moieties have been implemented in the structure of cleavable linkers [14] [15] [16] . Among them, two types of linkers; azobenzene (AZO) linker and dialkoxydiphenylsilane (DADPS) linker, have been utilized most widely 17, 18 . The AZO linker has been applied in studies of the reactive cysteinome 19, 20 and selenocysteinome 21 in addition to the monitoring of newly synthesized bacterial proteins 22 . The biotin portion of the AZO linker is cleaved off upon reduction of the azobenzene group using sodium dithionite resulting in the formation of a residual aminophenol moiety on the cleaved peptide. To date, the applications of the DADPS linker included: identification of glycosylation sites 23 , profiling the deubiquitinase family of proteins 24 , and mapping the sites of small-molecule protein interactions [25] [26] [27] . The biotin portion of the DADPS linker is cleaved using formic acid leaving a hydroxyl moiety on the peptide adduct.
While each linker has been applied in numerous studies, so far there has been little understanding behind the criteria for their selection for a specific experimental application. Therefore, we decided to compare the performance of the AZO and DADPS cleavable linkers under similar experimental conditions. We were interested in understanding if any differences in the experimental results would arise through application of either reagent. To this end, we employed both linkers in an effort to profile the cellular cysteinome. Considering previous utilization of the AZO linker in characterizing the cysteinome, our goal was not to simply recapitulate reported work but to also investigate potential improvements to currently existing protocols. Moreover, in our studies, we took advantage of a mass tolerant search strategy with MSFragger 28 software which allowed for the identification of unexpected modifications of the evaluated cleavable linkers. Finally, we demonstrated the utility of the developed methods in identifying the protein interactome of dacomitinib, a recently FDA-approved inhibitor of epidermal growth factor receptor (EGFR) kinase. This effort resulted in a better understanding of the selectivity profile of dacomitinib as well as the consequences of proteome modulation by this small molecule.
Results and Discussion
In order to conduct a head-to-head comparison of the performance of the azobenzene (AZO) and dialkoxydiphenylsilane (DADPS) chemically-cleavable linkers in characterizing the cellular cysteinome ( Figure 1B) , we utilized the cysteine residue-reactive probe iodoacetamide alkyne (IAAyne) as it has been successfully deployed in chemical proteomic applications 11, 19 , and serves as a tool to profile cysteine-reactive covalent drugs used for disease indications 29 . We initiated our studies by subjecting 1 mg of lysate derived from K562 chronic myelogenous leukemia cells to alkylation in the presence of IAAyne (100 µM). This was followed by CuAAC-mediated derivatization of IAAyne-modified cysteines using either cleavable biotin azide. Subsequently, standard chloroform-methanol precipitation was used to remove excess CuAAC reagents.
Previous reports suggested that streptavidin-biotin enrichment conducted after proteolysis could result in a higher number of identifications than enrichment conducted prior to protein digestion [30] [31] [32] . We therefore decided to perform two enrichment approaches in parallel to understand how either method would affect the total number of identifications. For the first sample, biotinmediated enrichment followed protein digestion while for the second sample the enrichment was performed prior to proteolysis ( Figure 1C -D). Following enrichment and stringent washing, samples were subjected to chemical cleavage with sodium dithionite (AZO) or 10% formic acid (DADPS) to enable removal of the biotin moiety and isolation of the IAAyne-modified peptide adducts from the streptavidin resin. Samples were desalted using StageTips and LC-MS/MS analysis was conducted using a Thermo Orbitrap Fusion MS.
Label-free analysis using MaxQuant was performed to identify unique cysteine residues that could be isolated using either cleavable biotin linker. We analyzed the number of unique cysteine residues in each replicate and tabulated cysteine residues which had a localization probability greater than 0.80. Only localization scores from singly-modified cysteine containing peptides were used. Consequently, 11,400 and 10,316 unique cysteine residues were identified with the use of the DADPS linker when peptide and protein enrichment were performed, respectively. 7866 cysteine residues were identified in all three replicates when enrichment was performed post proteolysis, and 6676 cysteine residues were identified in all three replicates when enrichment was performed prior to proteolysis ( Figure 2A ). The application of the AZO linker enabled the identification of 9362 and 6664 total unique cysteine residues when performing peptide and protein enrichment, respectively. 4326 cysteine residues were identified in all three replicates when enrichment was performed after proteolysis, and 2795 cysteine residues were identified in all three replicates when enrichment was performed prior to proteolysis ( Figure 2B ). Overall, comparison of the four datasets demonstrated that the application of the DADPS biotin linker yielded the greatest number of unique cysteine residues when enrichment was performed after proteolytic digestion ( Figure 2 & Table 1 ). A sizeable discrepancy was observed when the AZO linker was utilized indifferent of the enrichment method as each respective method yielded approximately twice as many unique identifications when the DADPS linker was applied. We decided to analyze the total number of proteins that would be identified from an on-bead digest when using either linker for enrichment of proteins prior to proteolytic digestion. Our expectation was that equivalent numbers of protein groups should be identified when controlling for the amount of material being labeled during the CuAAC reaction. Indeed, comparison of protein groups identified through the application of either linker did not reveal bias in enrichment of proteins, with either reagent capturing 90% of the 3502 protein groups identified ( Figure  3A ). In contrast, there was only a 54% overlap between the AZO and DADPS linkers when comparing identified cysteine residues in aggregate. This constituted 7612 cysteine residues out of a total of 14,098. 29.7% of the cysteines were exclusively identified when using the DADPS linker, while only 15% of the cysteine residues were exclusively identified when using AZO linker ( Figure 3B ).
We were interested in understanding whether the discrepancies between the number of identified cysteine residues could be attributed to an incorrect mass calculation for variable modifications during database searching or whether the presence of an additional uncharacterized modification resulted in a fewer number of identified unique cysteine residues when the AZO linker was utilized. To address these questions, we performed mass tolerant database searching with MSFragger 28 . Mass tolerant searching enables the identification of modifications that are not accounted for during a closed search with preset variable modifications and it has been demonstrated to increase the number of identifications from tandem mass spectra 33 . In order to attain high mass accuracy required for the mass tolerant database analysis, samples were re-acquired using MS2 scans detected by the Orbitrap. By performing the database search with a fixed modification of +57 Da for cysteine carbamidomethylation, we observed the expected mass differences of +216.1 Da and +181.1 Da for the AZO linker and DADPS linker respectively, which corresponded to the expected residual masses resulting from chemical cleavage ( Figure 3B ).
Furthermore, we concluded that the presence of additional peptide spectrum matches with an observed modification (+244.1 Da for AZO and +209.1 Da for DADPS) corresponding to a difference of approximately 28 Da from the expected residual modification mass of either cleavable linker could be attributed to the formylation of S/T/K residues or N-termini 34, 35 . Finally, a unique mass shift of +296.1 Da was only observed in peptide spectrum matches from peptides that were enriched using the AZO linker ( Figure 3B ). Site localization of the +296.1 Da modification using PTMProphet assigned the modification to cysteine residues, suggesting that the cleaved residual AZO linker modification was being additionally modified by a mass of +80 Da (Supp Fig 1A) . Taking into account the reductive conditions using sodium dithionite for cleavage of the AZO linker, we considered sulfation as a potential source of the mass difference in detected peptides. Such a mass difference, identified in only one of the two datasets, pointed towards artifactual modification of the cleavable linker, reducing the likelihood that a biologically relevant modification such as phosphorylation (+79.96633 Da) was observed.
It has been previously demonstrated that sodium dithionite could undergo decomposition to thiosulfate in phosphate-buffered saline under low pH conditions 36, 37 . Presence of thiosulfate could on the other hand result in artifactual sulfation of peptides 38 . We hypothesized that the aminophenol moiety formed after cleavage of the AZO linker could be a likely target of sulfation. We reasoned that the addition of an acid to the eluent prior to peptide desalting, a well-established part of the sample preparation protocol 19, 39 , could be the likely cause of dithionite decomposition. We therefore decided to conduct additional analysis and included the AZO-SULFO modification as a variable modification during database searching. Consequently, searching the cleavable linker data with the addition of the AZO-SULFO modification using MaxQuant resulted in the identification of a total of 10,000 unique cysteine residues. We identified 3856 unique AZO-SULFO modified cysteine residues in all three replicates (Supp Fig 1B) . A substantial overlap (32%) between AZO and AZO-SULFO modified cysteine residues was observed, suggesting that sequence-unique cysteine residues existed in either modification form in the acquired data set (Supp Fig 1B) . We reasoned that this finding might explain the discrepancy between the total number of cysteine residues identified when comparing the DADPS linker and AZO linker.
To further interrogate the source of observed artifactual modification of peptides resulting from the application of the AZO linker, we conducted an experiment in which recombinant glutathione Stransferase omega 1 (GSTO1) protein, previously reported to possess a highly reactive cysteine residue in its active site 11 , was incubated with IAAyne and subsequently subjected to CuAAC-mediated labeling with the AZO linker. This was followed by cleavage of the biotin portion with sodium dithionite. Prior to protein precipitation the obtained samples were subjected to incubation with or without the addition of formic acid in order to understand the potential role this reagent played in the occurrence of the AZO-SULFO modification. Interestingly, the AZO-SULFO modification on the peptide corresponding to the active site of GSTO1 was detected under both conditions (Supp Fig 2) . Based on these results, we hypothesized that the potential decomposition of sodium dithionite occurred prior to the addition of formic acid. This could suggest that either reagents used for CuAAC labeling or sample processing for mass spectrometry might not be directly compatible with the application of sodium dithionite. However, this hypothesis would require further empirical validation.
Upon completion of our comparative study resulting in the identification of the DADPS linker as the more suitable reagent for chemical proteomic analysis of the cellular cysteinome, we decided to evaluate the applicability of the developed methods to characterize the protein-interactome of a druglike molecule. We selected the covalent EGFR kinase inhibitor dacomitinib, which was recently approved for the treatment of non-small cell lung cancer 40, 41 . Dacomitinib is a pan-erythroblastic leukemia viral oncogene homologue (ERBB) inhibitor which targets wildtype and mutant forms of EGFR that possess activating L858R or exon 19 deletion mutations in addition to T790M mutation 42, 43 . For the purpose of our study, we utilized the A431 epidermoid cancer cell line as it was previously reported to be characterized by a high expression of wildtype EGFR 44 , and has been utilized in experiments profiling EGFR covalent inhibitors 45, 46 .
Previous reports indicated that the application of multiplexed labeling strategies for cleavable linkers could result in the identification of several thousand unique peptides within a single experiment when using reductive dimethyl and iTRAQ labeling strategies 47, 48 . We therefore decided to implement a recently published protocol 49 utilizing TMT labeling in combination with the DADPS linker (Supp Fig 3A) . To this end, A431 epidermoid cancer cells were treated in the presence or absence of dacomitinib (5 µM) for 2 hours. Cells were harvested and cell extracts were subjected to labeling using a dacomitinib alkyne-derived probe. This was followed by CuAAC-mediated labeling to tag targets of the probe with a fluorophore (Supp Fig 3B) . In-gel fluorescence analysis of treated samples as well as complementary immunoblot analysis using a phospho-specific antibody probing the activation status of EGFR confirmed on-target binding and successful inhibition of EGFR (Supp Fig 3C-D) . Subsequently, cell lysates were incubated with IAAyne (100 µM) and derivatized with the DADPS linker. Proteomes were precipitated, washed, and proteolytically cleaved. TMT6plex labeling was performed using three replicate experiments and samples were analyzed using a Thermo Fusion Lumos MS. After data normalization and analysis ( Supp Fig 4 & 5) , a total of 10,201 unique cysteine residues were identified which represented a nearly 3-fold increase over recent studies in the number of unique cysteine residues observed when using IAAyne and a cleavable linker in a single experiment 50 . While the majority of the proteome and cysteinome were found to be unperturbed, a small proportion of quantified cysteine residues exceeded a magnitude log 2 fold change of one which represented more than four standard deviations from the mean (Figure 4 ). We identified modulated cysteine residues that revealed increased or decreased labeling by the IAAyne probe in response to dacomitinib treatment. 15 cysteine residues corresponding to the sequence of EGFR did not demonstrate modulation, while the cysteine residue corresponding to the sequence of the active site of EGFR (C797) was not identified, likely due to the size of the peptide generated upon tryptic digestion.
Interestingly, modulated cysteine residues occurred on several proteins where a single cysteine residue was perturbed relative to all other cysteine residues located on the respective protein (Supp Fig  6A) . First, we identified C190 from Cyclin-G-associated kinase (GAK) that was engaged by IAAyne only in the absence of dacomitinib suggesting direct binding of dacomitinib to the kinase. This cysteine residue has been previously reported to be located next to the highly conserved DFG motif, which in an active kinase state coordinates magnesium ion in the ATP binding site 51 . Interestingly, a structurally similar analog of dacomitinib, FDA-approved EGFR inhibitor gefitinib, has also been demonstrated to target GAK 29, 52, 53 . Additionally, GAK C190 has been recently characterized as a target of a SM1-71, a promiscuous covalent kinase inhibitor 54 .
Another cysteine residue that was observed to undergo modulation upon treatment with dacomitinib was C218, localized in close proximity to the active site of glycogen synthase kinase-3 beta (GSK3B). Interestingly, C218 was reported to be proximal to Y216 and phosphorylation of Y216 has been demonstrated to be required for GSK3B activity 55 . In our study, treatment with dacomitinib reduced phosphorylation of Y216 which was confirmed by immunoblot analysis (Supp Fig 6B) . It has been previously reported that an electro-negative environment within the structure of a protein could destabilize the thiolate form and increase the pK a of a cysteine [56] [57] [58] . In fact, the lack of change in protein abundance levels between dacomitinib treatment and control confirmed by immunoblot analysis (Supp Fig 6B) could suggest that upon reduction in GSK3B phosphorylation status, C218 becomes more nucleophilic and therefore more labeling of this cysteine residue occurred upon IAAyne treatment.
The increased labeling of a cysteine residue by IAAyne in response to dacomitinib treatment was also observed for another kinase, pyruvate dehydrogenase kinase 1 (PDK1). PDK1 C240 is proximal to a tyrosine phosphorylation site (Y243) which has been previously reported to be regulated by FGFR1 and is required for PDK1 activity 59 . Previous proteomic studies have categorized this cysteine residue as hyper-reactive 20 . Moreover, it has been demonstrated that upon treatment with tyrosine kinase inhibitor TKI258, decreased phosphorylation of PDK1 Y243 results in decreased activity of PDK1 59 . The results of these reports combined with our proteomic analysis suggested that C240 reactivity could be governed by the phosphorylation status of the neighboring Y243 residue. As previously reported these findings may reflect potential cross-talk of cysteine reactivity with phosphorylation of proximal amino acid residues 60, 61 .
Instances of modulation where all cysteine residues identified from a protein were perturbed were also discovered. We identified three cysteine residues corresponding to the sequence of Fosrelated antigen 1 (FOSL1), a transcription factor involved in the response to serum stimulation. It has been previously reported that upon serum stimulation, FOSL1 transcription increases and the protein is translated 62 . We confirmed by immunoblot that FOSL1 expression increased in the vehicle treatment and was down-regulated when cells were treated with dacomitinib (Supp Fig 6B) . Our treatment conditions utilized fresh serum-containing media therefore the effect observed relative to the control treatment matched the effect of perturbation using dacomitinib. Interestingly, in a different example where a cysteine residue corresponding to the sequence of nuclear receptor subfamily 4 group A member 1 (NR4A1) was identified, changes in NR4A1 protein abundance were not observed despite the fact that NR4A1 has been previously implicated as a serum-responsive transcriptional regulator (Supp Fig 6B) 63 . While additional analysis would be required, these data suggested that NR4A1 C551 itself might be a direct target of dacomitinib and this interaction could play a role in interfering with serummediated transcriptional activation.
Overall, by taking into consideration the nature of our experiments, a general assessment of the type of identified cysteine residues allowed us to classify them into two categories. The first category included 10 out of 10,201 identified cysteine residues which were found to undergo a higher degree of labeling by IAAyne in the absence of dacomitinib. These cysteine residues could represent direct targets that were bound by dacomitinib or indirect targets which decreased in abundance in response to dacomitinib treatment. 18 cysteine residues comprised a second category, namely residues that were found to undergo a higher degree of labeling by IAAyne when cells were treated with dacomitinib relative to control treatment. These indirect effects may be due to increased protein abundance as a result of dacomitinib treatment or changes in cysteine reactivity due to differential regulation of posttranslational modifications as a result of dacomitinib treatment.
In our study, we set out to compare two widely-used chemically-cleavable biotin linkers, previously applied in a variety of chemical proteomic studies. By conducting parallel profiling of the cellular cysteinome, we identified significant discrepancies between the number of identified cysteine residues enabled through the application of each of the linkers. Namely, we found that the application of the DADPS linker led to identification of a higher number of unique cysteine residues than the application of the AZO linker. Mass tolerant database searching using MSFragger enabled detection of an unexpected modification that was the possible source of the observed discrepancies. Specifically, we identified an artifactual modification in the form of sulfation on the azobenzene cleavable linker. This finding suggests that the utility of the AZO linker in chemical proteomic applications could be hindered as a substantial proportion of modification sites could become sulfated, potentially interfering with quantitative aspects of the assay or foregoing detection entirely. On the contrary, the compatibility of the cleavage conditions used to cleave the DADPS linker with mass spectrometry sample preparation protocols suits its application in profiling reactive sites in proteomes and makes it broadly applicable for characterizing small molecule protein interactomes.
Methods
Detailed experimental methods can be found in the supporting information.
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Figure 3. Analysis of yield discrepancies between AZO and DADPS linkers.
A) Venn diagram of protein groups and reactive sites identified by either linker. Nearly identical number of protein groups were identified between data sets generated from on-bead digests through the application of the AZO linker and DADPS linker. In contrast, comparison of the total number of unique cysteine residues revealed a difference between the same data sets. B) MSFragger was used for a mass tolerant search to identify possible modifications missed in preliminary database searches. "Assigned modifications" represent modifications that were included as default during database searching (M oxidation +15.99490 Da and C carbamidomethylation +57.021464 Da) and "observed modifications" represent modifications that were not preset in database searches. Identification of a mass shift unique to the AZO linker (+80 Da) suggested possible artifactual modification of peptides when using this reagent. Waterfall plot depicting cysteine residues identified using IAAyne in competition with the EGFR covalent inhibitor dacomitinib in cellular extracts derived from A431 cells. Cysteine residues that were competed or modulated to a greater extent than a magnitude log 2 fold change of 1 are labeled with respective gene symbol and residue sequence position.
